These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18639569)

  • 1. Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53.
    Simões ML; Hockley SL; Schwerdtle T; Gamboa da Costa G; Schmeiser HH; Phillips DH; Arlt VM
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):86-98. PubMed ID: 18639569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice.
    Arlt VM; Zuo J; Trenz K; Roufosse CA; Lord GM; Nortier JL; Schmeiser HH; Hollstein M; Phillips DH
    Int J Cancer; 2011 Jan; 128(1):21-32. PubMed ID: 20232387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro.
    Sborchia M; De Prez EG; Antoine MH; Bienfait L; Indra R; Valbuena G; Phillips DH; Nortier JL; Stiborová M; Keun HC; Arlt VM
    Arch Toxicol; 2019 Nov; 93(11):3345-3366. PubMed ID: 31602497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo.
    Sborchia M; Keun HC; Phillips DH; Arlt VM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells.
    Bellamri M; Brandt K; Brown CV; Wu MT; Turesky RJ
    Arch Toxicol; 2021 Jun; 95(6):2189-2199. PubMed ID: 33938965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro.
    Li Y; Liu Z; Guo X; Shu J; Chen Z; Li L
    Arch Toxicol; 2006 Aug; 80(8):524-32. PubMed ID: 16609888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aristolochic acid suppresses DNA repair and triggers oxidative DNA damage in human kidney proximal tubular cells.
    Chen YY; Chung JG; Wu HC; Bau DT; Wu KY; Kao ST; Hsiang CY; Ho TY; Chiang SY
    Oncol Rep; 2010 Jul; 24(1):141-53. PubMed ID: 20514455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR.
    Arlt VM; Schmeiser HH; Pfeifer GP
    Carcinogenesis; 2001 Jan; 22(1):133-40. PubMed ID: 11159751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.
    Arlt VM; Meinl W; Florian S; Nagy E; Barta F; Thomann M; Mrizova I; Krais AM; Liu M; Richards M; Mirza A; Kopka K; Phillips DH; Glatt H; Stiborova M; Schmeiser HH
    Arch Toxicol; 2017 Apr; 91(4):1957-1975. PubMed ID: 27557898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
    Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
    Arlt VM; Stiborova M; Schmeiser HH
    Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.
    Hollstein M; Moriya M; Grollman AP; Olivier M
    Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
    Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
    Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.
    Slade N; Moll UM; Brdar B; Zorić A; Jelaković B
    Mutat Res; 2009 Apr; 663(1-2):1-6. PubMed ID: 19428366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification through microarray gene expression analysis of cellular responses to benzo(a)pyrene and its diol-epoxide that are dependent or independent of p53.
    Hockley SL; Arlt VM; Jahnke G; Hartwig A; Giddings I; Phillips DH
    Carcinogenesis; 2008 Jan; 29(1):202-10. PubMed ID: 17942461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP53 mutations in p53-negative dysplastic urothelial cells from Belgian AAN patients: New evidence for aristolochic acid-induced molecular pathogenesis and carcinogenesis.
    Aydin S; Ambroise J; Cosyns JP; Gala JL
    Mutat Res Genet Toxicol Environ Mutagen; 2017 Jun; 818():17-26. PubMed ID: 28477877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
    Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
    J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.